Medical White Papers

RSS

Medical White Papers are in-depth articles aimed to educate and inform site visitors interested in medical research. Some of these papers are derived from sources where we have existing commercial relationships. Such articles are clearly labelled as sponsored content and are only accepted when the content is deemed to add value to the core editorial ethos of News Medical.

Multiplex Immunohistochemistry: An Introduction

Multiplex Immunohistochemistry: An Introduction

Understanding the tumor microenvironment is a huge challenge. Immunohistochemistry is a tool to examine protein expression, activation, and distribution. It has a variety of applications across many scientific fields.

From Bethyl Laboratories, Inc. 1 Mar 2021

Albumin: A Marker of Tissue Damage and Organ Function

Albumin: A Marker of Tissue Damage and Organ Function

Albumin has several applications across a variety of molecular biology and biomedical fields. Bethyl’s Mouse Albumin ELISA kit is a versatile reagent that can be utilized as a marker for organ function and tissue damage.

From Bethyl Laboratories, Inc. 1 Mar 2021

Checkpoint Blockade Therapies: Ushering in the Second Wave

Checkpoint Blockade Therapies: Ushering in the Second Wave

Checkpoint blockade therapies are becoming more and more commonplace as they are a useful tool against tumors. They work by reactivating immune cells present in a tumor to attack and potentially destroy the cancerous cells.

From Bethyl Laboratories, Inc. 1 Mar 2021

Using Bethyl Laboratories Antibodies to Improve T-Cell Marker Research

Using Bethyl Laboratories Antibodies to Improve T-Cell Marker Research

T-Cell marker panels allow for the identification of T-cells associated with tumors. This allows researchers to identify and therefore target T-cell subpopulations that are associated with cancers.

From Bethyl Laboratories, Inc. 28 Feb 2021

Reagent Validation Via ENCODE: A Free, Publicly Funded Source

Reagent Validation Via ENCODE: A Free, Publicly Funded Source

ENCODE is a NIH funded effort to provide data on the human genome. It's antibody database allows for the cross referencing of various brands and cell lines in order to get the best reagent for your needs.

From Bethyl Laboratories, Inc. 27 Feb 2021

Mobile Air Quality Monitoring with Real-Time Mobile VOC Monitors

Mobile Air Quality Monitoring with Real-Time Mobile VOC Monitors

IONICON real-time mobile VOC monitors are frequently operated in mobile measurement labs and are utilized for mobile air quality monitoring.

From Ionicon Analytik Ges.m.b.H. 23 Feb 2021

Innovation and the Mastery of Core Technologies are the Keys for the Success of Bio-Pharmaceutical Enterprises

Innovation and the Mastery of Core Technologies are the Keys for the Success of Bio-Pharmaceutical Enterprises

At the beginning of 2020, when COVID-19 broke out unexpectedly and viciously, top research institutions and enterprises in China responded quickly, and the virus antibody R&D team of Sino Biological Inc. was one of them.

19 Jan 2021

Research and Development Progress of a SARS-CoV-2 Neutralizing Antibody

Research and Development Progress of a SARS-CoV-2 Neutralizing Antibody

It has been one year since the outbreak of COVID-19, but there is still an increasing number of confirmed cases. The epidemic situation is still challenged all over the world.

19 Jan 2021

Developing a Phase Appropriate CMC Program

Developing a Phase Appropriate CMC Program

From funding, regulatory guidance, timing and outsourcing there are a lot of factors in developing a phase appropriate CMC program.

From DSI, a PLG Company 22 Jul 2020

Development Plan for CMC Strategy

Development Plan for CMC Strategy

Chemistry, manufacturing and controls are a key quality marker of emerging biotech companies and require a clear development plan for CMC strategy.

From DSI, a PLG Company 22 Jul 2020

What You Need to Understand About CMC Regulatory Affairs

What You Need to Understand About CMC Regulatory Affairs

Providing an overview of what you need to understand about CMC regulatory affairs and information to be reviewed as part of routine drug development activities.

From DSI, a PLG Company 22 Jul 2020

CMC Discussion Topics Around Your Product Development

CMC Discussion Topics Around Your Product Development

Seeking early guidance from regulators can be invaluable and there are plenty of CNC discussion topics that should be raised during your product development.

From DSI, a PLG Company 22 Jul 2020

Regulatory Considerations Moving from Phase 2 to Phase 3

Regulatory Considerations Moving from Phase 2 to Phase 3

ROI is a crucial consideration when moving from phase 2 to phase three on the path to pharmaceutical product approval. This article describes the opportunities.

From DSI, a PLG Company 22 Jul 2020

Seeing the forest for the trees: CMC and Regulatory Affairs

Seeing the forest for the trees: CMC and Regulatory Affairs

With ever changing guidelines for emerging biotech companies, it's important to see the overall picture of CMC and regulatory affairs.

From DSI, a PLG Company 22 Jul 2020

Accepting Appropriate Regulatory CMC Risk

Accepting Appropriate Regulatory CMC Risk

Understanding the best ways to communicate between IND sponsors and the FDA during drug development can inform the appropriate regulatory CMC risk.

From DSI, a PLG Company 14 Jul 2020

Successful CMC Regulatory Affairs

Successful CMC Regulatory Affairs

Chemistry, manufacturing and control (CMC) regulatory affairs is a fast growing titan and must be approached appropriately during drug development.

From DSI, a PLG Company 14 Jul 2020

Drug Development CMC Considerations

Drug Development CMC Considerations

Emerging Biotech companies rarely have a sizeable chmistry, manufacturing and controls group and so during drug development there is often not much thought put to CMC considerations

From DSI, a PLG Company 9 Jul 2020

FDA End of Phase II CMC Meeting Preparation

FDA End of Phase II CMC Meeting Preparation

There are three rules of engagement recommended for the end of an end of phase II CMC meeting with the FDA. This article discusses this approach.

From DSI, a PLG Company 9 Jul 2020

A Short History of Gene Therapies

A Short History of Gene Therapies

This article details the history of the differing types of gene therapies.

From OXGENE 1 Jun 2020

The Role of HEK293 Cells in Gene Therapy

The Role of HEK293 Cells in Gene Therapy

This article details how gene therapy has been, and is still being, influenced by HEK293 cells.

From OXGENE 20 May 2020

Previous
1
...
34
35
36
37
38
39
40
...
46
Next

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.